Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Robak

Showing results (281-290 of 292) with videos related to

Pageof 30
Sort By:
Bone Marrow Transplantation|April 20, 2004
Treatment for primary refractory Hodgkin's disease: a comparison of high-dose chemotherapy followed by ASCT with conventional therapyJ Czyz, R Szydlo, W Knopinska-Posluszny, et al.
Medical Oncology (Northwood, London, England)|January 10, 2002
Rituximab (Mabthera, Rituxan) in patients with recurrent indolent lymphoma: evaluation of safety and efficacy in a multicenter studyJ Walewski, E Kraszewska, O Mioduszewska, et al.
Leukemia & Lymphoma|June 1, 1996
2-chlorodeoxyadenosine (2-CdA) in 2-hour versus 24-hour intravenous infusion in the treatment of patients with hairy cell leukemiaT Robak, M Błasińska-Morawiec, E Krykowski, et al.
Blood|October 7, 2000
Cladribine with prednisone versus chlorambucil with prednisone as first-line therapy in chronic lymphocytic leukemia: report of a prospective, randomized, multicenter trialT Robak, J Z Bloński, M Kasznicki, et al.
British Journal of Haematology|February 26, 2000
Cladribine with or without prednisone in the treatment of previously treated and untreated B-cell chronic lymphocytic leukaemia - updated results of the multicentre study of 378 patientsT Robak, J Z Bloński, M Kasznicki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 28, 2004
Outcome and prognostic factors in advanced Hodgkin's disease treated with high-dose chemotherapy and autologous stem cell transplantation: a study of 341 patientsJ Czyz, R Dziadziuszko, W Knopinska-Postuszuy, et al.
Leukemia|March 5, 2004
Addition of cladribine to daunorubicin and cytarabine increases complete remission rate after a single course of induction treatment in acute myeloid leukemia. Multicenter, phase III studyJ Holowiecki, S Grosicki, T Robak, et al.
Leukemia & Lymphoma|August 1, 1996
Intermittent 2-hour intravenous infusions of 2-chlorodeoxyadenosine in the treatment of 110 patients with refractory or previously untreated B-cell chronic lymphocytic leukemiaT Robak, M Błasinka-Morawiec, E Krykowski, et al.
Bone Marrow Transplantation|September 12, 2007
The influence of palifermin (Kepivance) on oral mucositis and acute graft versus host disease in patients with hematological diseases undergoing hematopoietic stem cell transplantB Nasilowska-Adamska, P Rzepecki, J Manko, et al.
Acta Haematologica Polonica|July 1, 1981
[Treatment of acute leukemias in adults. IV. Treatment results on 375 patients at 9 hematology centers]D Apel, M Bielawiec, A Bodzenta, et al.
Pageof 30

Showing results (281-290 of 292) with videos related to

Sort By:
Pageof 30
Bone Marrow Transplantation|April 20, 2004
Treatment for primary refractory Hodgkin's disease: a comparison of high-dose chemotherapy followed by ASCT with conventional therapyJ Czyz, R Szydlo, W Knopinska-Posluszny, et al.
Medical Oncology (Northwood, London, England)|January 10, 2002
Rituximab (Mabthera, Rituxan) in patients with recurrent indolent lymphoma: evaluation of safety and efficacy in a multicenter studyJ Walewski, E Kraszewska, O Mioduszewska, et al.
Leukemia & Lymphoma|June 1, 1996
2-chlorodeoxyadenosine (2-CdA) in 2-hour versus 24-hour intravenous infusion in the treatment of patients with hairy cell leukemiaT Robak, M Błasińska-Morawiec, E Krykowski, et al.
Blood|October 7, 2000
Cladribine with prednisone versus chlorambucil with prednisone as first-line therapy in chronic lymphocytic leukemia: report of a prospective, randomized, multicenter trialT Robak, J Z Bloński, M Kasznicki, et al.
British Journal of Haematology|February 26, 2000
Cladribine with or without prednisone in the treatment of previously treated and untreated B-cell chronic lymphocytic leukaemia - updated results of the multicentre study of 378 patientsT Robak, J Z Bloński, M Kasznicki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 28, 2004
Outcome and prognostic factors in advanced Hodgkin's disease treated with high-dose chemotherapy and autologous stem cell transplantation: a study of 341 patientsJ Czyz, R Dziadziuszko, W Knopinska-Postuszuy, et al.
Leukemia|March 5, 2004
Addition of cladribine to daunorubicin and cytarabine increases complete remission rate after a single course of induction treatment in acute myeloid leukemia. Multicenter, phase III studyJ Holowiecki, S Grosicki, T Robak, et al.
Leukemia & Lymphoma|August 1, 1996
Intermittent 2-hour intravenous infusions of 2-chlorodeoxyadenosine in the treatment of 110 patients with refractory or previously untreated B-cell chronic lymphocytic leukemiaT Robak, M Błasinka-Morawiec, E Krykowski, et al.
Bone Marrow Transplantation|September 12, 2007
The influence of palifermin (Kepivance) on oral mucositis and acute graft versus host disease in patients with hematological diseases undergoing hematopoietic stem cell transplantB Nasilowska-Adamska, P Rzepecki, J Manko, et al.
Acta Haematologica Polonica|July 1, 1981
[Treatment of acute leukemias in adults. IV. Treatment results on 375 patients at 9 hematology centers]D Apel, M Bielawiec, A Bodzenta, et al.
Pageof 30